These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20944646)

  • 1. siRNA knockdown of ribonucleotide reductase inhibits melanoma cell line proliferation alone or synergistically with temozolomide.
    Zuckerman JE; Hsueh T; Koya RC; Davis ME; Ribas A
    J Invest Dermatol; 2011 Feb; 131(2):453-60. PubMed ID: 20944646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small interfering RNA (siRNA)-mediated silencing of the M2 subunit of ribonucleotide reductase: a novel therapeutic strategy in ovarian cancer.
    Zhang M; Wang J; Yao R; Wang L
    Int J Gynecol Cancer; 2013 May; 23(4):659-66. PubMed ID: 23466567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SiRNA-Mediated
    Xue T; Wang L; Li Y; Song H; Chu H; Yang H; Guo A; Jiao J
    Int J Med Sci; 2019; 16(11):1510-1516. PubMed ID: 31673243
    [No Abstract]   [Full Text] [Related]  

  • 4. Potent siRNA inhibitors of ribonucleotide reductase subunit RRM2 reduce cell proliferation in vitro and in vivo.
    Heidel JD; Liu JY; Yen Y; Zhou B; Heale BS; Rossi JJ; Bartlett DW; Davis ME
    Clin Cancer Res; 2007 Apr; 13(7):2207-15. PubMed ID: 17404105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of RRM2 inhibits cell proliferation, causes cell cycle arrest and promotes the apoptosis of human neuroblastoma cells and in human neuroblastoma RRM2 is suppressed following chemotherapy.
    Li J; Pang J; Liu Y; Zhang J; Zhang C; Shen G; Song L
    Oncol Rep; 2018 Jul; 40(1):355-360. PubMed ID: 29749541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined effect of temozolomide and hyperthermia on human melanoma cell growth and O6-methylguanine-DNA methyltransferase activity.
    Pagani E; Falcinelli S; Pepponi R; Turriziani M; Caporaso P; Caporali S; Bonmassar E; D'Atri S
    Int J Oncol; 2007 Feb; 30(2):443-51. PubMed ID: 17203227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifolate activity of pyrimethamine enhances temozolomide-induced cytotoxicity in melanoma cells.
    Chen M; Osman I; Orlow SJ
    Mol Cancer Res; 2009 May; 7(5):703-12. PubMed ID: 19435820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cyclin-dependent kinase inhibitor PHA-848125 suppresses the in vitro growth of human melanomas sensitive or resistant to temozolomide, and shows synergistic effects in combination with this triazene compound.
    Caporali S; Alvino E; Starace G; Ciomei M; Brasca MG; Levati L; Garbin A; Castiglia D; Covaciu C; Bonmassar E; D'Atri S
    Pharmacol Res; 2010 May; 61(5):437-48. PubMed ID: 20026273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Fighting SiRNA-RRM2 Loaded Nanorobots.
    Sharma A; Kumar P; Ambasta RK
    Pharm Nanotechnol; 2020; 8(2):79-90. PubMed ID: 32003677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting ribonucleotide reductase M2 subunit by small interfering RNA exerts anti-oncogenic effects in gastric adenocarcinoma.
    Kang W; Tong JH; Chan AW; Zhao J; Wang S; Dong Y; Sin FM; Yeung S; Cheng AS; Yu J; To K
    Oncol Rep; 2014 Jun; 31(6):2579-86. PubMed ID: 24756820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of hepatocellular carcinoma growth using immunoliposomes for co-delivery of adriamycin and ribonucleotide reductase M2 siRNA.
    Gao J; Chen H; Yu Y; Song J; Song H; Su X; Li W; Tong X; Qian W; Wang H; Dai J; Guo Y
    Biomaterials; 2013 Dec; 34(38):10084-98. PubMed ID: 24060417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E2F1 promote the aggressiveness of human colorectal cancer by activating the ribonucleotide reductase small subunit M2.
    Fang Z; Gong C; Liu H; Zhang X; Mei L; Song M; Qiu L; Luo S; Zhu Z; Zhang R; Gu H; Chen X
    Biochem Biophys Res Commun; 2015 Aug; 464(2):407-15. PubMed ID: 26093293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A MYBL2 complex for RRM2 transactivation and the synthetic effect of MYBL2 knockdown with WEE1 inhibition against colorectal cancer.
    Liu Q; Guo L; Qi H; Lou M; Wang R; Hai B; Xu K; Zhu L; Ding Y; Li C; Xie L; Shen J; Xiang X; Shao J
    Cell Death Dis; 2021 Jul; 12(7):683. PubMed ID: 34234118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parthenolide enhances dacarbazine activity against melanoma cells.
    Koprowska K; Hartman ML; Sztiller-Sikorska M; Czyz ME
    Anticancer Drugs; 2013 Sep; 24(8):835-45. PubMed ID: 23797801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma model.
    Mathieu V; Le Mercier M; De Neve N; Sauvage S; Gras T; Roland I; Lefranc F; Kiss R
    J Invest Dermatol; 2007 Oct; 127(10):2399-410. PubMed ID: 17495956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining adenoviral oncolysis with temozolomide improves cell killing of melanoma cells.
    Quirin C; Mainka A; Hesse A; Nettelbeck DM
    Int J Cancer; 2007 Dec; 121(12):2801-7. PubMed ID: 17724714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication.
    Aghi M; Rabkin S; Martuza RL
    J Natl Cancer Inst; 2006 Jan; 98(1):38-50. PubMed ID: 16391370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53R2 is a prognostic factor of melanoma and regulates proliferation and chemosensitivity of melanoma cells.
    Matsushita S; Ikeda R; Fukushige T; Tajitsu Y; Gunshin K; Okumura H; Ushiyama M; Akiyama S; Kawai K; Takeda Y; Yamada K; Kanekura T
    J Dermatol Sci; 2012 Oct; 68(1):19-24. PubMed ID: 22902076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of ribonucleotide reductase M2 subunit in gastric cancer and effects of RRM2 inhibition in vitro.
    Morikawa T; Hino R; Uozaki H; Maeda D; Ushiku T; Shinozaki A; Sakatani T; Fukayama M
    Hum Pathol; 2010 Dec; 41(12):1742-8. PubMed ID: 20825972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing livin gene by siRNA leads to apoptosis induction, cell cycle arrest, and proliferation inhibition in malignant melanoma LiBr cells.
    Wang H; Tan SS; Wang XY; Liu DH; Yu CS; Bai ZL; He DL; Zhao J
    Acta Pharmacol Sin; 2007 Dec; 28(12):1968-74. PubMed ID: 18031611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.